DURECT Corporation (DRRX) Fundamentals

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States.
SHARE INFORMATION
Market Cap$ 131,738,709
Shares Outstanding227,764,019
Float198,082,094
Percent Float86.97%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 13,977,000
Latest Fiscal EPS$ -0.16
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions228
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months10,920,978
Institutional Holdings Percent55.9%
Institutional Sold Previous 3 Months36,414,903
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months855,738
Insider Holdings Percent2.6
Insider Sold Previous 3 Months-
Insider Shares Owned6,014,574
TRADING INFO
52 Week High$ 1.32
52 Week Low$ 0.36
52 Week High Change$ -52.20
21 Day Moving Average$ 0.6029
21 Day Extended Moving Average$ 0.60613
50 Day Moving Average$ 0.6574
50 Day Extended Moving Average$ 0.619215
200 Day Moving Average$ 0.612928
200 Day Extended Moving Average$ 0.708424
10 Day Average Volume237,134
20 Day Average Volume242,773
30 Day Average Volume253,722
50 Day Average Volume371,179
Alpha0.004543
Beta1.2571
Standard Deviation0.263263
R20.061987
7 Day Price Change$ 0.0139
7 Day Percent Change2.46%
21 Day Price Change$ -0.1034
21 Day Percent Change-15.17%
30 Day Price Change$ -0.1416
30 Day Percent Change-19.67%
Month to Date Price Change$ 0.0002
Month to Date Percent Change0.03%
Quarter to Date Price Change$ 0.0002
Quarter to Date Percent Change0.03%
180 Day Price Change$ 0.0028
180 Day Percent Change0.49%
200 Day Price Change$ -0.125
200 Day Percent Change-17.77%
Year to Date Price Change$ -0.4075
Year to Date Percent Change-41.33%

DURECT Corporation (DRRX) Key Ratios

PROFITABILITY
EBIT Margin-276.2%
EBITDA Margin-274.0%
Pre-Tax Profit Margin-74.6%
Profit Margin Count-45.21%
Gross Margin85.3%
Profit Margin TOT-2.29%
INCOME STATEMENTS
Revenue$ 11,288,000
Revenue Per Share$ 0.0496
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.40
Total Debt To Equity0.70
Int Coverage-16.80
Current Ratio5.70
Leverage Ratio1.80
Quick Ratio5.20
Long Term Debt To Capital0.36
VALUATION MEASURES
PE Ratio-3.50
Enterprise Value$ 104,014,442
Price to Sales11.6707
Price to Free Cash-5.00
PE High Last 5 Years-8.70
Price To Book3.70
Price To Cash Flow288.60
PE Low Last 5 Years-87.00
Price to Tangible Book4.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover10.80
Invoice Turnover0.90
Assets Turnover0.20
Return Assets-48.06
Return on Equity-77.50
Return on Capital-47.16

DURECT Corporation (DRRX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOJames E. Brown
Emplyoees78
Last AuditUQ
CIK0001082038
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address10260 Bubb Road
Cupertino, CA 95014-4166
Websitehttp://www.durect.com
Facsimile+1 408 777-3577
Telephone+1 408 777-1417
Emailmike.arenberg@durect.com


Your Recent History
NASDAQ
DRRX
Durect
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.